Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  ElectroCore, Inc.    ECOR

ELECTROCORE, INC.

(ECOR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/26/2020 10/27/2020 10/28/2020 10/29/2020 10/30/2020 Date
1.61(c) 1.61(c) 1.51(c) 1.47(c) 1.51(c) Last
241 995 251 599 577 712 536 640 362 633 Volume
-3.59% 0.00% -6.21% -2.65% +2.72% Change
More quotes
Financials (USD)
Sales 2020 3,68 M - -
Net income 2020 -24,2 M - -
Net Debt 2020 - - -
P/E ratio 2020 -2,31x
Yield 2020 -
Sales 2021 7,86 M - -
Net income 2021 -20,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,06x
Yield 2021 -
Capitalization 65,5 M 65,5 M -
Capi. / Sales 2020 17,8x
Capi. / Sales 2021 8,33x
Nbr of Employees 51
Free-Float 78,6%
More Financials
Company
ElectroCore, Inc., formerly ElectroCore LLC, is a commercial-stage bioelectronic medicine healthcare company. The Company is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and respiratory fields. The Company's gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy, which... 
More about the company
Notations Surperformance© of electroCore, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about ELECTROCORE, INC.
10/21ELECTROCORE : Appoints Business Development Leader and US Navy Veteran Sylvester..
AQ
10/21electroCore, Inc. Appoints Business Development Leader and US Navy Veteran Sy..
GL
10/13ELECTROCORE, INC. : Results of Operations and Financial Condition, Regulation FD..
AQ
10/13ELECTROCORE : Provides Business Update and Select Financial Guidance
AQ
10/13electroCore Provides Business Update and Select Financial Guidance
GL
10/01ELECTROCORE : Announces Extension of NHS England's Innovation and Technology Pay..
AQ
10/01electroCore, Inc. Announces Extension of NHS England's Innovation and Technol..
GL
09/30ELECTROCORE : Announces Department of Veterans Affairs Sponsored Study of Non-In..
AQ
09/30electroCore Announces Department of Veterans Affairs Sponsored Study of Non-I..
GL
09/24ELECTROCORE : Announces Agreement with UpScript, LLC to be Exclusive Online Tele..
AQ
09/24electroCore Announces Agreement with UpScript, LLC to be Exclusive Online Tel..
GL
09/23ELECTROCORE : to Participate in the JMP Securities MedTech Bio Summit
AQ
09/23electroCore to Participate in the JMP Securities MedTech Bio Summit
GL
09/11electroCore to Present at the HC Wainwright Virtual 22nd Annual Global Invest..
GL
09/11ELECTROCORE : to Present at the HC Wainwright Virtual 22nd Annual Global Investm..
AQ
More news
News in other languages on ELECTROCORE, INC.

- No features available -

More news
Chart ELECTROCORE, INC.
Duration : Period :
electroCore, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELECTROCORE, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 3,75 $
Last Close Price 1,47 $
Spread / Highest target 240%
Spread / Average Target 155%
Spread / Lowest Target 104%
EPS Revisions
Managers
NameTitle
Daniel S. Goldberger Chief Executive Officer & Director
Michael G. Atieh Chairman
Michael Romaniw Vice President-Operations, Systems & Logistics
Brian M. Posner Secretary, Chief Financial & Accounting Officer
Peter S. Staats Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ELECTROCORE, INC.-7.55%65
NOVOCURE LIMITED46.28%12 462
MASIMO CORPORATION42.78%12 425
ASAHI INTECC CO., LTD.1.09%8 131
GETINGE AB-0.11%5 302
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.52.02%4 767